HIV/AIDS Dossier Update
-----------------------
Dear Reader,
The e-mail sent out on Friday regarding the new HIV/AIDS dossier
contained incorrect URLs for news, opinions, features, key docu-
ments and links.
Please accept my apologies and see amended version below.
Kind regards,
Jemima Tonks
mailto:Jemima.Tonks@scidev.net
--
Re: New HIV/AIDS Dossier
We have just launched a range of new in-depth materials on the
latest scientific and technological advances to combat HIV/AIDS
in developing countries. Articles include perspectives from the
South, with an overview of HIV research in Brazil and microbi-
cides research in South Africa forming two of the new opinion
pieces.
www.scidev.net/dossiers
By bringing together topical coverage and background resources,
this in-depth guide charts recent developments and indicates
promising new avenues of research.
It includes relevant news
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierItems&type=1&dossier=22
feature
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierItems&type=2&dossier=22
and opinion articles
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierItems&type=3&dossier=22
together with annotated links to essential reading
http://www.scidev.net/dossiers/index.cfm?fuseaction=keydocs&dossier=22
and other HIV/AIDS organisations
http://www.scidev.net/dossiers/index.cfm?fuseaction=links&dossier=22
'Key documents' come from a variety of sources: peer-reviewed
scientific journals (including Nature and Science), interna-
tional agencies, research sponsors, and campaign groups. They
are either freely available on the Internet, or granted access
by special permission.
Latest opinion articles:
Rules of engagement: human rights in HIV/AIDS trials
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierReadItem&type=3&itemid=410&language=1&dossier=22
Bebe Loff argues that ethical treatment of research participants
from vulnerable populations means more than considering harmful
drug side-effects; researchers must also frame their work within
a human rights context.
Community outreach: microbicides trials show the way
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierreaditem&dossier=22&type=3&itemid=413&language=1
Microbicide researchers have many lessons to share with HIV vac-
cine researchers in recruitment and retention of participants,
community partnerships, and developing acceptable standards of
care, says Gita Ramjee.
Vaccine research needs to cover all bases
http://www.scidev.net/dossiers/index.cfm?fuseaction=dossierreaditem&dossier=22&type=3&itemid=412&language=1
To address the urgency of the HIV crisis, says Mauro Schechter,
vaccine researchers must pursue clinical trials as well as basic
science, testing vaccines for both prevention and therapy.
Recent key documents:
Behind the veil of a public health crisis: HIV/AIDS in the Mus-
lim world
http://www.aei.org/docLib/20050608_eberstadtNBRreport.pdf
Laura M. Kelly and Nicholas Eberstadt - June 2005
This report from the US-based National Bureau of Asian Research
takes an unusual look at the HIV/AIDS situation in the Muslim
world, highlighting the poor surveillance and inadequate knowl-
edge of the extent of HIV/AIDS.
The development of vaginal microbicides for the prevention of
HIV transmission
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020142#JOURNAL-PMED-0020142-T001
Jonathan Weber, Kamal Desai, Janet Darbyshire, on behalf of the
Microbicides Development Programme - May 2005
This short online review summarises the current status of micro-
bicides research, describing in clear and concise terms the dif-
ferent types of microbicides currently in clinical trials, how
they act, and their potential shortcomings.
The material we provide is intended to equip readers at all lev-
els of expertise with an understanding of both the basics and
the potential of HIV/AIDS research, and its future direction. We
hope that it is helpful to educators, scientists, doctors,
healthcare providers and policymakers in developing countries.
New material will be continuously added to our latest dossier
and we welcome your feedback and suggestions. If you would like
to comment on this or any other resource please:
mailto:info@scidev.net
Please do take the time to pass on this information to your
friends and colleagues who will find it a valuable resource. If
you have not already done so, you might also like to register to
SciDev.Net http://www.scidev.net/register for automatic updates
on topics of interest and the free weekly email with all the
latest news, views and notices about science, technology and de-
velopment.
Please accept our apologies if you have previously received this
message through cross-posting. If you are already registered
with us and would like to update your details, or cancel your
registration please go to http://www.scidev.net/register
Kind regards,
Jemima Tonks
Marketing Officer
SciDev.Net
mailto:dossiers@scidev.net
The Science and Development Network (www.scidev.net) is the
world's leading electronic source of news, views and analysis
about science, technology and the developing world.